Conventional vs pathogen-inactivated platelet concentrates for the treatment of perioperative coagulopathy: A prospective cohort study;Konventionelle vs. pathogen-inaktivierte Thrombozytenkonzentrate bei perioperativer Koagulopathie: Eine prospektive Kohortenstudie

Chirurg

Volumn 82, Issue 4, 2011, Pages 348-358

  Weber, C F ^a   Meininger, D ^a   Byhahn, C ^a   Seifried, E ^a   Zacharowski, K ^a   Adam, E ^b   Henschler, R ^a   Muller M M ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Multiple electrode aggregometry; Pathogen inactivation; Perioperative coagulopathy; Platelet concentrate; Platelet count

Indexed keywords

PSORALEN DERIVATIVE; S 59, PSORALEN; S-59, PSORALEN;

AGED; ARTICLE; BLOOD BUFFY COAT; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD STORAGE; BLOODBORNE BACTERIUM; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GERMANY; HEART DISEASE; HUMAN; INTENSIVE CARE UNIT; MALE; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE; PROSPECTIVE STUDY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; ULTRAVIOLET RADIATION;

AGED; AGED, 80 AND OVER; BLOOD BUFFY COAT; BLOOD COAGULATION TESTS; BLOOD PRESERVATION; BLOOD-BORNE PATHOGENS; COHORT STUDIES; FEMALE; GERMANY; HEART DISEASES; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET TRANSFUSION; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; PSORALENS; ULTRAVIOLET RAYS;

EID: 79953331404     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-010-2023-2     Document Type: Article

References (30)

1. Apelseth TO, Bruserud O, Wentzel-Larsen T et al (2010) Therapeutic efficacy of platelet transfusion in Patients with acute leukemia: an evaluation of methods. Transfusion 50: 766-775.
2. Blajchman MA, Beckers EA, Dickmeiss E et al (2005) Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 19: 259-272.
3. Bundesärztekammer (2008) Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 4. Aufl. Deutscher Ärzteverlag, Köln.
4. Bundesärztekammer (2010) Thrombozytenkonzentrate. In: Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Deutscher Ärzteverlag, Köln, S 41ff.
5. Burger R, Offergeld R (2008) Festlegung der Haltbarkeitsfrist von Thrombozytenkonzentraten mit dem Ziel der Reduktion lebensbedrohlicher septischer Transfusionsreaktionen durch bakterielle Kontamination. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 12: 1484.
6. Cardinal DC, Flower RJ (1980) The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 3: 135-158.
7. Cauwenberghs S, van Pampus E, Curvers J et al (2007) Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 21: 287-294.
8. Daly PA, Schiffer CA, Aisner J et al (1980) Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA 243: 435-438.
9. Hanke AA, Roberg K, Monaca E et al (2010) Impact of platelet count on results obtained from Multiple Electrode Platelet Aggregometry (Multiplate™). Eur J Med Res 15: 214-219.
10. Hanke AA, Dellweg C, Kienbaum P et al (2010) Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. Anaesthesia 65: 688-691.
11. Innerhofer P, Kienast J (2010) Principles of perioperative coagulopathy. Best Pract Res Clin Anaesthesiol 24: 1-14.
12. Jacobs MR, Palavecino E, Yomtovian R (2001) Don't bug me: the problem of bacterial contamination of blood components - challenges and solutions. Transfusion 41: 1331-1334.
13. Jámbor C, Weber C, Beesel K van et al (2008) In vitro platelet function of platelet concentrates transfused to high risk cardiac surgery Patients as determined bedside by the multiplate impedance aggregometry. Eur J Anaesthesiol 25: 6AP2-1 (Abstr).
14. Jansen GA, van Vliet HH, Vermeij H et al (2004) Functional characteristics of photochemically treated platelets. Transfusion 44: 313-319.
15. Kluter H, Dorges L, Maass E et al (1996) In-vivo evaluation of random donor platelet concentrates from pooled buffy coats. Ann Hematol 73: 85-89.
16. McCullough J, Vesole DH, Benjamin RJ et al (2004) Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 104: 1534-1541.
17. Ness P, Braine H, King K et al (2001) Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 41: 857-861.
18. Palavecino EL, Yomtovian RA, Jacobs MR (2006) Detecting bacterial contamination in platelet products. Clin Lab 52: 443-456.
19. Picker SM, Schneider V, Oustianskaia L et al (2009) Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion 49: 2311-2318.
20. Pineda A, McCullough J, Benjamin RJ et al (2006) Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial. Transfusion 46: 562-571.
21. Rood IG, Pettersson A, Savelkoul PH et al (2010) Development of a reverse transcription-polymerase chain reaction assay for eubacterial RNA detection in platelet concentrates. Transfusion 50: 1352-1358.
22. Schrezenmeier H, Walther-Wenke G, Muller TH et al (2007) Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 47: 644-652.
23. Sohngen D, Schneider W (1991) Thrombocyte transfusion: clinical aspects, follow-up and complications. Klin Wochenschr 69: 379-386.
24. Toth O, Calatzis A, Penz S et al (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96: 781-788.
25. Tynngard N (2009) Preparation, storage and quality control of platelet concentrates. Transfus Apher Sci 41: 97-104.
26. van Rhenen D, Gulliksson H, Cazenave JP et al (2003) Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 101: 2426-2433.
27. Weber CF, Dietrich W, Spannagl M et al (2010) A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in Patients after cardiac surgery. Anesth Analg 110: 702-707.
28. Weber CF, Schneider AC, Kirschning T et al (2009) Therapeutic options for perioperatively acquired platelet dysfunctions. Anaesthesist 58: 931-940.
29. Wollowitz S (2001) Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol 38: 4-11.
30. Yomtovian R (2004) Bacterial contamination of blood: lessons from the past and road map for the future. Transfusion 44: 450-460.